血友病治療薬の世界市場2016-2020

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR10470)
◆英語タイトル:Global Hemophilia Drugs Market 2016-2020
◆発行会社/調査会社:Technavio
◆商品コード:IRTNTR10470
◆発行日:2016年10月19日
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:84
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[血友病治療薬の世界市場2016-2020]についてメールでお問い合わせはこちら
当調査レポートでは、血友病治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、血友病治療薬の世界市場規模及び予測、種類別分析、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
*** レポート概要(サマリー)***

About Hemophilia
Hemophilia is an X-linked genetic disorder that results in excessive blood loss during an injury, causing fatigue or even death. The disorder is more common in males and affects roughly 400,000 people globally every year. Hemophilia A is the more common form of this disorder, while hemophilia B is the rare form of hemophilia. To mitigate this disorder, plasma-derived clotting factors or recombinant clotting factors have been developed and are administered to the affected individual. The therapy is usually done in two ways: short acting therapeutic and long-acting therapeutic.

Technavio’s analysts forecast the global hemophilia drugs market to grow at a CAGR of 4.76% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global hemophilia drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of of drugs used for the treatment of hemophilia, including hemophilia A, hemophilia B, and inhibitors.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Hemophilia Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Baxalta
• Bayer
• CSL Behring
• Novo Nordisk
• Pfizer

[Other prominent vendors]
• Alnylam Pharmaceuticals
• Amarna Therapeutics
• Asklepios BioPharmaceutical
• Biogen
• BioMarin
• Catalyst Bioscience
• Chiesi Farmaceutici
• Dimension Therapeutics
• Emergent BioSolutions
• F. Hoffmann-La Roche
• Grifols, Kedrion Biopharma
• Octapharma
• rEVO Biologics
• OPKO Biologics
• Sangamo Biosciences
• Spark Therapeutics
• Swedish Orphan Biovitrum
• UniQure Biopharma.

[Market driver]
• Focus on prophylactic treatment
• For a full, detailed list, view our report

[Market challenge]
• Low diagnosis rate
• For a full, detailed list, view our report

[Market trend]
• Increase in technological innovations
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

*** レポート目次(コンテンツ)***

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Pipeline portfolio

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Market segmentation by type of disease
• Global hemophilia A drugs market
• Global hemophilia inhibitors treatment market
• Global hemophilia B drugs market
• Global von Willebrand disease treatment market

PART 08: Market segmentation by type of therapy
• Recombinant therapies
• Plasma-derived therapies

PART 09: Market segmentation by type of disease management
• Prophylaxis
• On-demand therapy
• Inhibitor therapy

PART 10: Geographical segmentation
• Hemophilia drugs market in Americas
• Hemophilia drugs market in EMEA
• Hemophilia drugs market in APAC

PART 11: Market drivers
• Focus on prophylactic treatment
• Drugs with prolonged action
• Improved diagnostic procedures

PART 12: Impact of drivers

PART 13: Market challenges
• Low diagnosis rate
• High entry barriers
• Cost-intensive complex treatment

PART 14: Impact of drivers and challenges

PART 15: Market trends
• Increase in technological innovations
• Development of gene therapy products
• Centralized buyers should pave the way to increased penetration

PART 16: Vendor landscape
• Competitive scenario
• Other prominent vendors

PART 17: Key vendor analysis
• Baxalta
• Bayer
• CSL Behring
• Novo Nordisk
• Pfizer

PART 18: Appendix
• List of abbreviations

PART 19: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Process of gene therapy
Exhibit 03: Key buying criteria for global hemophilia drugs market 2015
Exhibit 04: Key customer segments of hemophilia drugs market
Exhibit 05: Pipeline portfolio: Global hemophilia drugs market
Exhibit 06: Pipeline share of major companies
Exhibit 07: Global hemophilia drugs market snapshot: Developed and emerging markets 2015
Exhibit 08: Global hemophilia drugs market 2015-2020 ($ billions)
Exhibit 09: Impact of factors affecting the market 2015 and 2020
Exhibit 10: Five forces analysis
Exhibit 11: Segmentation of global hemophilia drugs market by disease type based on revenue 2015
Exhibit 12: Global hemophilia drugs market segmentation growth lifecycle analysis
Exhibit 13: Global hemophilia drugs market by disease type 2015-2020
Exhibit 14: Global hemophilia A drugs market 2015-2020 ($ billions)
Exhibit 15: Global hemophilia inhibitors treatment market 2015-2020 ($ billions)
Exhibit 16: Global hemophilia B drugs market 2015-2020 ($ billions)
Exhibit 17: Global von Willebrand disease treatment market 2015-2020 ($ millions)
Exhibit 18: Segmentation of global hemophilia drugs market by type of therapy based on revenue 2015
Exhibit 19: Global hemophilia drugs market by type of therapy 2015-2020
Exhibit 20: Recombinant therapies in global hemophilia drugs market 2015-2020 ($ billions)
Exhibit 21: Plasma-derived therapies in global hemophilia drugs market 2015-2020 ($ billions)
Exhibit 22: Segmentation of hemophilia inhibitors treatment market by type of disease management based on revenue 2015
Exhibit 23: Global hemophilia drugs market by geography 2015-2020
Exhibit 24: Percentage share of global hemophilia drugs market by geography 2015 and 2020
Exhibit 25: Global hemophilia drugs market segmentation by geography 2015-2020 ($ billions)
Exhibit 26: Global share of hemophilia drugs market by geography 2015
Exhibit 27: Global hemophilia drugs market segmentation by region: Market growth lifecycle analysis 2015
Exhibit 28: Global hemophilia drugs market: Country analysis based on revenue and growth rate
Exhibit 29: Opportunity analysis of hemophilia drugs market in Americas
Exhibit 30: Hemophilia drugs market in Americas 2015-2020 ($ billions)
Exhibit 31: Opportunity analysis of hemophilia drugs market in EMEA
Exhibit 32: Hemophilia drugs market in EMEA 2015-2020 ($ billions)
Exhibit 33: Opportunity analysis of hemophilia drugs market in APAC
Exhibit 34: Hemophilia drugs market in APAC 2015-2020 ($ billions)
Exhibit 35: Impact of drivers
Exhibit 36: Percentage share of diagnosed and undiagnosed hemophilia population 2012-2016
Exhibit 37: Impact of drivers and challenges
Exhibit 38: Gene therapies under development for hemophilia
Exhibit 39: Market share of vendors 2015
Exhibit 40: Geographical presence of key vendors
Exhibit 41: Competitive scenario of global hemophilia drugs market vendors 2015-2020
Exhibit 42: Baxalta: Strength assessment
Exhibit 43: Baxalta: Strategy assessment
Exhibit 44: Baxalta: Opportunity assessment
Exhibit 45: Baxalta: YoY revenue and growth rates of hemophilia drugs 2013-2015 ($ billions)
Exhibit 46: Bayer: Strength assessment
Exhibit 47: Bayer: Strategy assessment
Exhibit 48: Bayer: Opportunity assessment
Exhibit 49: Bayer: YoY revenue and growth rate of Kogenate FS 2013-2015 ($ billions)
Exhibit 50: CSL Behring: Strength assessment
Exhibit 51: CSL Behring strategy assessment
Exhibit 52: CSL Behring opportunity assessment
Exhibit 53: CSL Behring: YoY revenue and growth rate of hemophilia drugs 2013-2015 ($ billions)
Exhibit 54: Novo Nordisk: Strength assessment
Exhibit 55: Novo Nordisk: Strategy assessment
Exhibit 56: Novo Nordisk: Opportunity assessment
Exhibit 57: Novo Nordisk: YoY revenue and growth rates of hemophilia drugs 2013-2015 ($ billions)
Exhibit 58: Pfizer: Strength assessment
Exhibit 59: Pfizer: Strategy assessment
Exhibit 60: Pfizer: Opportunity assessment
Exhibit 61: Pfizer: Revenue of ReFacto AF/XYNTHA and BeneFIX 2015 ($ millions)



*** 掲載企業 ***

Baxalta, Bayer, CSL Behring, Novo Nordisk, Pfizer, Alnylam Pharmaceuticals, Amarna Therapeutics, Asklepios BioPharmaceutical, Biogen, BioMarin, Catalyst Biosciences, Chiesi Farmaceutici, Dimension Therapeutics, Emergent BioSolutions, F. Hoffmann-La Roche, Grifols, Kedrion Biopharma, Octapharma, rEVO Biologics, OPKO Biologics, Sangamo Biosciences, Spark Therapeutics, Swedish Orphan Biovitrum, UniQure Biopharma.

*** レポートのキーワード ***

血友病治療薬、血友病A薬、血友病B薬、医療、医薬品

*** 調査方法 ***

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • アルゼンチンのポリイソブチレン市場2016-2020
    About The report brings together facts and figures about polyisobutylene market in Argentina covering period of 2009-2019. Statistics, experts’ opinions and estimations are given. The report about polyisobutylene market in Argentina covers: - manufacturers capacity, production volumes - company prof …
  • SATCOM装置の世界市場予測(~2022年):製品(レシーバー、送信機/トランスポンダー、トランシーバー、アンテナ、モデム/ルータ)、技術、用途、産業、地域別分析
    “Factors such as growing need for uninterrupted communication in various industries and increasing use of SATCOM equipment in space exploration, telecommunication, & telemetry will drive the SATCOM equipment market.”The SATCOM equipment market is estimated to be USD 20.20 billion in 2017 and is proj …
  • 合成皮革の世界市場分析
    Future Market Insights relies on a strong research methodology to collect and analyse the researched data At Future Market Insights, a unique research methodology is applied to gather the necessary market intelligence. Secondary research followed by primary research and key opinions from domain expe …
  • 弾性ラミネートの世界市場:産業分析・市場機会
    In this report, FMI offers a 10-year forecast of the global elastic laminates market between 2018 and 2028. In terms of value, the elastic laminates market is forecast to expand at a CAGR of 5.6% during the forecast period. The study reveals the market dynamics in seven geographic segments along wit …
  • アーモンドオイルの世界市場2017-2021
    About Almond OilAlmond oil is an essential oil extracted from almonds and is used for cosmetic preparations, flavoring, and medicinal purposes. There are two types of almond oil: sweet almond oil and bitter almond oil. Sweet almond oil: It is a colorless or pale yellow fatty oil extracted from the s …
  • メタンの世界市場2020
    The Global Methane (CAS 74-82-8) Industry 2020 Market Research Report is a professional and in-depth study on the current state of the Methane industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. Th …
  • スペインのホルムアルデヒド市場2016-2020
    About The report brings together facts and figures about formaldehyde market in Spain covering period of 2009-2019. Statistics, experts’ opinions and estimations are given. The report about formaldehyde market in Spain covers: - manufacturers capacity, production volumes - company profiles - consump …
  • 中国の酸化チタン市場2016-2020
    About The report brings together facts and figures about titanium dioxide market in China covering period of 2009-2019. Statistics, experts’ opinions and estimations are given. The report about titanium dioxide market in China covers: - manufacturers capacity, production volumes - company profiles - …
  • 電動キッチンミキサーの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Electric Kitchen Mixer Revenue, means the sales value of Electric Kitchen Mixer This report studies sales (consumption) of Electric Kitchen Mixer in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/cou …
  • 民間航空機用キャビンインテリアの世界市場2020-2024
    Commercial Aircraft Cabin Interiors Market 2020-2024 Technavio has been monitoring the commercial aircraft cabin interiors market, and it is poised to grow by USD 11.88 billion during 2020-2024, progressing at a CAGR of 9% during the forecast period. Our reports on commercial aircraft cabin interior …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR10470 )"血友病治療薬の世界市場2016-2020" (英文:Global Hemophilia Drugs Market 2016-2020)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。